FDA
approval
· 2025-10-28
FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approves a supplemental application for Tivicay (dolutegravir) from ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TIVICAY (DOLUTEGRAVIR SODIUM)